Walgreens estimates that a quarter of its 8,700 stores in the US are not profitable with CEO Tim Wentworth saying the company ...

At the beginning of the COVID-19 pandemic, ordering a COVID-19 test required a physician’s involvement, so Walgreens ...

The company is in the process of being taken private by Sycamore Partners in a deal that is expected to close in the fourth ...

The U.S. healthcare segment reported Q2 revenue of $2.2 billion, a decrease of $23 million, reflecting lower fee-for-service ...

Adjusted earnings came in at $0.63 per share for the three-month period ended Feb. 28, exceeding analyst expectations of ...

Walgreens is the latest US retail pharmacy giant to have a go at disrupting the clinical trials industry, with the launch of a new business unit that will tap into its reserve of patient data, as ...

Walgreens Boots Alliance reported stronger-than-expected second-quarter earnings Tuesday as the pharmacy chain accelerated ...